"10.1371_journal.pone.0105628","plos one","2014-09-03T00:00:00Z","Thomas Blauenfeldt; Jan Heyckendorf; Sidse Graff Jensen; Christoph Lange; Camilla Drabe; Thomas S Hermansen; Lena de Thurah; Troels Lillebaek; Jesper Eugen-Olsen; Niels Seersholm; SÃ¸ren Hoff; Jesper Bonde; Morten Ruhwald","Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Clinical Infectious Diseases, German Center for Infection Research (DZIF) Tuberculosis Unit, Research Center Borstel, Borstel, Germany; Department of Pulmonary Medicine, Copenhagen University Hospital Gentofte, Copenhagen, Denmark; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark; Clinical Research Centre, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark; Department of Pathology, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark; Department of Medicine, University of Namibia School of Medicine, Windhoek, Namibia","Conceived and designed the experiments: TB MR JEO JB. Performed the experiments: TB JH SGJ CL CD LdT TSH SH MR NS. Analyzed the data: TB JB JEO MR. Contributed reagents/materials/analysis tools: MR JB CL NS TL. Contributed to the writing of the manuscript: MR TB CL JB.","The authors have read the journals policy and have the following competing interests: TB, MR, TSH, and SH are employed by Statens Serum Institut, Copenhagen Denmark, which holds several pending and issued patents and patent rights on M. tuberculosis specific antigens including ESAT-6 and CFP10. MR and JEO are registered as inventors on pending and issued patents held by Copenhagen University Hospital, Copenhagen, Denmark on the use of IP-10 as a diagnostic marker for infection with M. tuberculosis. JB has served as a paid advisor in the past to Roche Molecular Systems and Genomica SAU, and received honoraria from Hologic/Gen-Probe, Roche, Qiagen, BD Diagnostics and Genomica for lectures. CL received honoraria from Astra Zeneca, Chiesi, Novartis and Pfizer for speaking at industry sponsored symposia and from Archivel, Celltrion and MSD for participating in scientific advisory boards. TL is also employed by Statens Serum Institut but declares no conflicts of interest. Roche Denmark have provided PCR reagents at reduced cost. Roche employees were not involved in the study design, interpretation of results or preparation of the manuscript. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. The authors confirm that co-author Morten Ruhwald is a PLOS ONE Editorial Board member. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2014","09","Thomas Blauenfeldt","TB",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
